Clinical Roundup NeXT Personal MRD test predicts NSCLC outcomes, phase III trial shows September 12, 2025Vol.51 No.33
Clinical Roundup Pre- and post-surgery immunotherapy combination shows promise for mesothelioma, Johns Hopkins-led study shows September 12, 2025Vol.51 No.33
Clinical Roundup New genetic biomarker flags aggressive brain tumors, Mayo Clinic study finds September 12, 2025Vol.51 No.33
Clinical Roundup Novel tool helps identify key targets to strengthen CAR NK cell therapies, MD Anderson research shows September 12, 2025Vol.51 No.33
Clinical Roundup Cyclin A/B RxL inhibitors restore G1–S-checkpoint in treatment of small cell lung cancer, DFCI research shows September 12, 2025Vol.51 No.33
Clinical Roundup Preclinical study reveals how HPV reprograms immune cells to help cancer grow September 12, 2025Vol.51 No.33
Clinical Roundup Cancer Center at Illinois researcher unveils targeting technology for cancer immunotherapy September 12, 2025Vol.51 No.33
Clinical Roundup WashU Medicine genetic study suggests ways to catch blood cancer earlier September 12, 2025Vol.51 No.33
Clinical Roundup City of Hope study shows childhood cancer survivors face new health problems later in life September 05, 2025Vol.51 No.32
